Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas

The introduction of a newly developed target therapy for metastatic melanomas poses the challenge to have a good molecular stratification of those patients who may benefit from this therapeutic option. Practically, BRAF mutation status (V600E) is commonly screened although other non-V600E mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovanni, Ponti, Giovanni, Pellacani, Aldo, Tomasi, Pietro, Loschi, Gabriele, Luppi, Fabio, Gelsomino, Caterina, Longo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925612/
https://www.ncbi.nlm.nih.gov/pubmed/24591764
http://dx.doi.org/10.1155/2014/671283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925612/
https://www.ncbi.nlm.nih.gov/pubmed/24591764
http://dx.doi.org/10.1155/2014/671283

Ejemplares similares